Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor.
about
The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunityStromal cell regulation of homeostatic and inflammatory lymphoid organogenesisStromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic InflammationEndogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosisThe central role of antigen presentation in islets of Langerhans in autoimmune diabetesImmunotherapy of type 1 diabetes: lessons for other autoimmune diseases.Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity.Herpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations.CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice.Myeloid-derived suppressor cells prevent type 1 diabetes in murine modelsInnate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.Transgenic LacZ under control of Hec-6st regulatory sequences recapitulates endogenous gene expression on high endothelial venules.Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptorTolerance and lymphoid organ structure and function.Lymphotoxin and LIGHT signaling pathways and target genes.Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathyDifferential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues.All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.Cytokine related therapies for autoimmune diseaseBlockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic miceLIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro.LIGHT/IFN-γ triggers β cells apoptosis via NF-κB/Bcl2-dependent mitochondrial pathway.CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic miceMouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.LTβR and CD40: working together in dendritic cells to optimize immune responses.Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.Turning on LIGHT.A Lymphotoxin/Type I IFN Axis Programs CD8+ T Cells To Infiltrate a Self-Tissue and Propagate Immunopathology.Lymphotoxin pathway directs thymic Aire expression.Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta.Manifestation of spontaneous and early autoimmune gastritis in CCR7-deficient miceEffects of streptozotocin on autoimmune diabetes in NOD mice.Resident fibroblasts in the kidney: a major driver of fibrosis and inflammation.Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion
P2860
Q27025082-B2E70030-DCB8-4FB3-AD8A-10DC67C4D2AAQ27693895-C2E9927B-4D1F-4563-BF40-3EB8B41761D3Q28068106-973B2C71-8F8C-452C-94D0-A1949D87A864Q28207830-EA5F00F4-C0C5-44C3-93FD-9A8AD55F60F4Q33986306-82744338-AA08-482F-ABA7-DCE7738B81F5Q34731064-7B747BE8-CA25-40D1-BA1E-29256D3FA416Q34731168-FB152A13-3594-4B3E-91FC-55B52F8EFA3EQ35102246-F4001174-CDF1-4699-BFDC-3D264FE6B427Q35136409-F75F6A64-445D-47C7-A5BC-EE75A37F5DCFQ35166486-E1D79AEA-6F25-48DA-A193-9885DC10FD9CQ35627416-CEED6A5C-A72B-4B06-8EB5-4810E05390C3Q35679191-6BC2C032-9AA2-4AA5-8B25-DF14F9A90741Q35721598-448A6EF2-9955-490E-A11C-10ABCAC36188Q35723152-F735ED11-F7D6-4894-9AFE-CE961792E769Q35927529-20798F8A-A0A5-4EF2-8621-38665AFE5823Q35951798-40AA1687-EF94-4570-A16A-B4543CCEC056Q36225473-36B0C7E7-7604-4407-8E5F-FB542A6EA0B4Q36399104-EB0D3821-EDA3-4861-BA6F-30A3B32DDC0EQ36399452-BD396E3C-9F8E-4448-8D1B-066805574FCCQ36752354-FE4ACFB5-A3B0-41B5-90AA-D541EBA38CB8Q36991047-B32341E6-420D-41D5-A7C3-D3D99D32FF6EQ37023022-50C6BC27-06F1-4379-BA81-4178CA9F01E9Q37105570-8C95B1E9-A2F9-4CA3-A05A-D5A0A8CB52CEQ37207114-D2B44286-FFF8-4A7F-AC2E-3AEB3D12A035Q37242976-36102539-D353-4B9B-929C-C9CEDB22C078Q37251618-A7A4318B-131B-4F94-BCF2-7CD56768FCA2Q37299504-2586C694-4C7A-4ED5-8D05-5259A6D952CFQ37737987-40F8500C-63C3-4289-9878-AE2887AE4ECAQ37948123-B2352B63-B439-467E-81E8-6EB537AADF6CQ39245218-0CA5EC69-3C06-42BE-85A6-2EB776AD7246Q39947219-85021062-3036-4CA1-A4CB-89BC0B51B96CQ40440208-DA4AC74E-17F0-4D07-B4A0-A47C3A3CF0A4Q40630236-14AECC9D-7BCE-4708-8CEA-8E67AE145530Q41831341-BFB60EDF-C7C2-4697-BD65-15D708957350Q42128925-8FAF008F-609C-408D-9BC6-74436ECDC3AAQ44655252-5927BB5A-5CC6-44C4-A594-7392BCD3D9D8Q47165275-0268D191-6D49-4B28-85CF-01565BF87C25Q57083661-A60DABA0-C811-462A-9F74-650387814839
P2860
Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Reversal of spontaneous autoim ...... soluble lymphotoxin receptor.
@ast
Reversal of spontaneous autoim ...... soluble lymphotoxin receptor.
@en
type
label
Reversal of spontaneous autoim ...... soluble lymphotoxin receptor.
@ast
Reversal of spontaneous autoim ...... soluble lymphotoxin receptor.
@en
prefLabel
Reversal of spontaneous autoim ...... soluble lymphotoxin receptor.
@ast
Reversal of spontaneous autoim ...... soluble lymphotoxin receptor.
@en
P2093
P2860
P356
P1476
Reversal of spontaneous autoim ...... soluble lymphotoxin receptor.
@en
P2093
J A Bluestone
L M Hoffman
P2860
P304
P356
10.1084/JEM.193.11.1327
P407
P577
2001-06-01T00:00:00Z